The Lilabean Foundation for Pediatric Brain Cancer raises $900K

Mayo Clinic researchers identify personalized approach to brain cancer monitoring

Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most aggressive types of brain cancer.

April 25, 2025

Vol.51 No.16

Drugs & Targets

FDA grants Breakthrough Therapy designation for B7-H3 CAR T-cell therapy for diffuse intrinsic pontine glioma

BrainChild Bio Inc. announced that its investigational B7-H3 targeting autologous CAR T-cell therapy has been granted Breakthrough Therapy designation by FDA for the treatment of diffuse intrinsic pontine glioma, an incurable pediatric brain tumor.

April 25, 2025

Vol.51 No.16

Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing

Nov. 6, 2023, was a bad day for Tom Curran, a charming scientist with a lilting Scottish brogue and the lifelong dream of curing childhood cancers.

April 11, 2025

Vol.51 No.14

By Claire Marie Porter

Clinical Roundup

Pediatric oncology programs lack sufficient psychosocial resources, Nemours Children’s Health study finds

Families facing a childhood cancer diagnosis experience a range of psychological, social, and emotional stressors, from anxiety to financial strain to sibling concerns.

April 11, 2025

Vol.51 No.14

In Brief

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

Michael Chan was appointed chair of Wake Forest University’s Department of Radiation Oncology, which he has led as interim chair since 2023. In his permanent role, he will advance the clinical, research and education missions of the department, while optimizing care delivery and clinical operations.

March 28, 2025

Vol.51 No.12

Clinical Roundup

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

Researchers at the University of Texas Health Science Center at San Antonio have discovered a way to delay or even block recurrence of the deadliest brain cancer after radiation.

March 28, 2025

Vol.51 No.12

The Lilabean Foundation for Pediatric Brain Cancer raises $900K

YOU MAY BE INTERESTED IN

Mayo Clinic researchers identify personalized approach to brain cancer monitoring

FDA grants Breakthrough Therapy designation for B7-H3 CAR T-cell therapy for diffuse intrinsic pontine glioma

Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing

Pediatric oncology programs lack sufficient psychosocial resources, Nemours Children’s Health study finds

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

Renew today!

Subscriber content

The Lilabean Foundation for Pediatric Brain Cancer raises $900K

YOU MAY BE INTERESTED IN

Mayo Clinic researchers identify personalized approach to brain cancer monitoring

FDA grants Breakthrough Therapy designation for B7-H3 CAR T-cell therapy for diffuse intrinsic pontine glioma

Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s MercyWhistleblower lawsuit alleges wrongful firing

Pediatric oncology programs lack sufficient psychosocial resources, Nemours Children’s Health study finds

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing